Value of magnetic resonance perfusion imaging in the differential diagnosis of high-grade glioma
and single brain metastasis(PDF)
《中国医学物理学杂志》[ISSN:1005-202X/CN:44-1351/R]
- Issue:
- 2019年第7期
- Page:
- 808-810
- Research Field:
- 医学影像物理
- Publishing date:
Info
- Title:
- Value of magnetic resonance perfusion imaging in the differential diagnosis of high-grade glioma
and single brain metastasis
- Author(s):
- LIU Sheng
- Department of Radiology, Guilin People’s Hospital, Guilin 541002, China
- Keywords:
- Keywords: magnetic resonance perfusion imaging; high-grade glioma; single brain metastasis; differential diagnosis
- PACS:
- R445.2;R739.4
- DOI:
- DOI:10.3969/j.issn.1005-202X.2019.07.012
- Abstract:
- Abstract: Objective To study and evaluate the diagnostic value of magnetic resonance perfusion imaging in high- grade
glioma. Methods A total of 84 patients with pathologically confirmed high-grade glioma and 60 patients with single brain
metastasis were enrolled in the study. Dynamic contrast- enhanced magnetic resonance perfusion imaging was used to
measure the relative cerebral blood volume (rCBV) in tumor parenchyma and peritumor edema area, and a statistical analysis
was conducted on the obtained data. Results The time-signal intensity curve of high-grade glioma was different from that of
single brain metastasis. In tumor parenchyma, the rCBV of single brain metastasis was lower than that of high-grade glioma,
with statistical significance (4.03±0.79 vs 5.48±1.32, P<0.05). In the edema area, the rCBV of single brain metastasis was
0.74±0.35, lower than 1.48±0.26 of high-grade glioma, and the difference was statistically significant (P<0.05). Conclusion
Dynamic contrast-enhanced magnetic resonance perfusion imaging has a high clinical value in the differential diagnosis of
single brain metastasis and high-grade glioma.
Last Update: 2019-07-25